Audited Standalone Financial Results and Audited Standalone Financial Statements along with Auditor''s Report of the Company for the quarter and year ended March 31, 2025
Audited Standalone Financial Results And Audited Standalone Financial Statements Along With Auditor'S Report Of The Company For The Quarter And Year Ended March 31, 2025
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Welcure Drugs and Pharmaceuticals Ltd. on 6ix
Earlier from Welcure Drugs and Pharmaceuticals
- Board Meeting Outcome for Outcome Of Board Meeting
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 20 2025
- Board Meeting Intimation for For Consideration And Approval Of The Audited Financial ResultsFor The Quarter/Year Ended 31St March, 2025 Alongwith Statement Of Assets And Liabilities And Cash FlowStatement For The Year Ended 31St March, 2025
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 15 2025
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Later from Welcure Drugs and Pharmaceuticals
- Announcement under Regulation 30 (LODR)-Change in Management
- Announcement Pursuant To Regulation 32 Of SEBI (LODR) Regulations, 2015 - Non Applicability Of Filing Statement Of Deviation / Variation In Utilization Of Funds For Quarter And Year Ended 31St March, 2025
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Welcure Drugs And Pharmaceuticals Ltd. Press Release May 29 2025
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Follow Welcure Drugs and Pharmaceuticals into a list and get an email when it puts out news.
Follow Welcure Drugs and Pharmaceuticals